US Business

The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12.

Slower hiring is clouding a recovery that also faces new Covid uncertainties.

Vaccine seekers in some states face waits of days or weeks for doses as local health officials hustle to improve access to meet surging demand. CVS, Walgreens and Walmart, which are facing staffing shortages, now say they may not be able to accommodate people without appointments.

Shell is standing firm against Third Point’s call for a breakup to retain and attract investors. But that isn’t stopping Eni and other European energy conglomerates from targeting similar moves to boost shareholder returns.

Didi Global plans to delist its shares in the U.S. and pursue a listing in Hong Kong, a dramatic reversal just months after the Chinese ride-hailing group’s ill-fated initial public offering in New York.

Elon Musk has now unloaded more than $10 billion in Tesla stock as the billionaire’s share-selling spree involving his holdings in the electric-vehicle maker stretched into a second month.

The Federal Trade Commission sues to block the U.S. chip supplier’s proposed takeover of the chip-design specialist, arguing the deal is anticompetitive.

As part of the criminal-fraud trial of the former Theranos CEO, her lawyers submitted as exhibits handwritten notes she says she wrote about her daily schedule, plus instructions about how to conduct herself.

Marketers are staging sweepstakes, quizzes and events to gather people’s personal information and build detailed profiles—a response to Apple’s “opt in” policy for apps and Google’s plan to restrict user tracking in its browser.

Shares of casino operators tumbled on news of the suspension of Suncity VIP rooms, while the junket operator’s leader, Alvin Chau, resigned following his arrest on illegal gambling and money-laundering allegations.